| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4310100 | Surgery | 2008 | 10 Pages |
Abstract
p21 controls the intensity of the immune response posttransplantation, with overexpression inhibiting allograft rejection. Our data demonstrate that p21 controls T-cell priming and suggest that p21 and other cdk inhibitors may serve as potential targets for therapeutic manipulation of alloimmune responses.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Theodore H. MD, Guanyi MD, Keri PhD, Sherri C. BS, Lamis PhD, D. Keith PhD,